248 related articles for article (PubMed ID: 35562376)
1. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ.
Liu Y; Deguchi Y; Wei D; Liu F; Moussalli MJ; Deguchi E; Li D; Wang H; Valentin LA; Colby JK; Wang J; Zheng X; Ying H; Gagea M; Ji B; Shi J; Yao JC; Zuo X; Shureiqi I
Nat Commun; 2022 May; 13(1):2665. PubMed ID: 35562376
[TBL] [Abstract][Full Text] [Related]
2. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL4 accelerates KRAS
Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS
Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032
[TBL] [Abstract][Full Text] [Related]
4. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Keenan BP; Saenger Y; Kafrouni MI; Leubner A; Lauer P; Maitra A; Rucki AA; Gunderson AJ; Coussens LM; Brockstedt DG; Dubensky TW; Hassan R; Armstrong TD; Jaffee EM
Gastroenterology; 2014 Jun; 146(7):1784-94.e6. PubMed ID: 24607504
[TBL] [Abstract][Full Text] [Related]
5. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.
Philip B; Roland CL; Daniluk J; Liu Y; Chatterjee D; Gomez SB; Ji B; Huang H; Wang H; Fleming JB; Logsdon CD; Cruz-Monserrate Z
Gastroenterology; 2013 Dec; 145(6):1449-58. PubMed ID: 23958541
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.
Murphy SJ; Hart SN; Lima JF; Kipp BR; Klebig M; Winters JL; Szabo C; Zhang L; Eckloff BW; Petersen GM; Scherer SE; Gibbs RA; McWilliams RR; Vasmatzis G; Couch FJ
Gastroenterology; 2013 Nov; 145(5):1098-1109.e1. PubMed ID: 23912084
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia.
Wang H; Moniruzzaman R; Li L; Ji B; Liu Y; Zuo X; Abbasgholizadeh R; Zhao J; Liu G; Wang R; Tang H; Sun R; Su X; Tan TH; Maitra A; Wang H
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37140994
[TBL] [Abstract][Full Text] [Related]
9. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.
Carrière C; Gore AJ; Norris AM; Gunn JR; Young AL; Longnecker DS; Korc M
Gastroenterology; 2011 Sep; 141(3):1091-101. PubMed ID: 21699781
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic KRAS, Mucin 4, and Activin A-Mediated Fibroblast Activation Cooperate for PanIN Initiation.
Hu CM; Huang CC; Hsu MF; Chien HJ; Wu PJ; Chen YI; Jeng YM; Tang SC; Chung MH; Shen CN; Chang MC; Chang YT; Tien YW; Lee WH
Adv Sci (Weinh); 2023 Dec; 10(36):e2301240. PubMed ID: 37964407
[TBL] [Abstract][Full Text] [Related]
12. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
13. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia.
De La O JP; Emerson LL; Goodman JL; Froebe SC; Illum BE; Curtis AB; Murtaugh LC
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18907-12. PubMed ID: 19028876
[TBL] [Abstract][Full Text] [Related]
14. Target-Specific Nanoparticle Polyplex Down-Regulates Mutant
Smith JP; Chen W; Shivapurkar N; Gerber M; Tucker RD; Kallakury B; Dasa SSK; Kularatne RN; Stern ST
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614194
[TBL] [Abstract][Full Text] [Related]
15. Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.
De La O JP; Murtaugh LC
Cell Cycle; 2009 Jun; 8(12):1860-4. PubMed ID: 19440048
[TBL] [Abstract][Full Text] [Related]
16. Suppression of mutant Kirsten-RAS (KRAS
Kidger AM; Saville MK; Rushworth LK; Davidson J; Stellzig J; Ono M; Kuebelsbeck LA; Janssen KP; Holzmann B; Morton JP; Sansom OJ; Caunt CJ; Keyse SM
Oncogene; 2022 May; 41(20):2811-2823. PubMed ID: 35418690
[TBL] [Abstract][Full Text] [Related]
17. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
18. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.
Lesina M; Kurkowski MU; Ludes K; Rose-John S; Treiber M; Klöppel G; Yoshimura A; Reindl W; Sipos B; Akira S; Schmid RM; Algül H
Cancer Cell; 2011 Apr; 19(4):456-69. PubMed ID: 21481788
[TBL] [Abstract][Full Text] [Related]
19. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
[TBL] [Abstract][Full Text] [Related]
20. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA
Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
